BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 9195229)

  • 1. NF1 mutation analysis using a combined heteroduplex/SSCP approach.
    Abernathy CR; Rasmussen SA; Stalker HJ; Zori R; Driscoll DJ; Williams CA; Kousseff BG; Wallace MR
    Hum Mutat; 1997; 9(6):548-54. PubMed ID: 9195229
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular analysis of neurofibromatosis type 1 mutations.
    Weiming X; Yu Q; Lizhi L; Ponder M; Wallace M; Gangfeng X; Ponder B
    Hum Mutat; 1992; 1(6):474-7. PubMed ID: 1301957
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Two NF1 mutations: frameshift in the GAP-related domain, and loss of two codons toward the 3' end of the gene.
    Abernathy CR; Colman SD; Kousseff BG; Wallace MR
    Hum Mutat; 1994; 3(4):347-52. PubMed ID: 8081387
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NF1 gene analysis based on DHPLC.
    De Luca A; Buccino A; Gianni D; Mangino M; Giustini S; Richetta A; Divona L; Calvieri S; Mingarelli R; Dallapiccola B
    Hum Mutat; 2003 Feb; 21(2):171-2. PubMed ID: 12552569
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exhaustive mutation analysis of the NF1 gene allows identification of 95% of mutations and reveals a high frequency of unusual splicing defects.
    Messiaen LM; Callens T; Mortier G; Beysen D; Vandenbroucke I; Van Roy N; Speleman F; Paepe AD
    Hum Mutat; 2000; 15(6):541-55. PubMed ID: 10862084
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NF1 gene mutations in Japanese with neurofibromatosis 1 (NF1).
    Hatta N; Horiuchi T; Watanabe I; Kobayashi Y; Shirakata Y; Ohtsuka H; Minami T; Ueda K; Kokoroishi T; Fujita S
    Biochem Biophys Res Commun; 1995 Jul; 212(2):697-704. PubMed ID: 7542886
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comprehensive survey of mutations in the OPA1 gene in patients with autosomal dominant optic atrophy.
    Thiselton DL; Alexander C; Taanman JW; Brooks S; Rosenberg T; Eiberg H; Andreasson S; Van Regemorter N; Munier FL; Moore AT; Bhattacharya SS; Votruba M
    Invest Ophthalmol Vis Sci; 2002 Jun; 43(6):1715-24. PubMed ID: 12036970
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ten novel mutations in the human neurofibromatosis type 1 (NF1) gene in Italian patients.
    Origone P; De Luca A; Bellini C; Buccino A; Mingarelli R; Costabel S; La Rosa C; Garrè C; Coviello DA; Ajmar F; Dallapiccola B; Bonioli E
    Hum Mutat; 2002 Jul; 20(1):74-5. PubMed ID: 12112660
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alport syndrome. Molecular genetic aspects.
    Hertz JM
    Dan Med Bull; 2009 Aug; 56(3):105-52. PubMed ID: 19728970
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutation screening of neurofibromatosis type 1 (NF1) exons 28 and 29 with single strand conformation polymorphism (SSCP): five novel mutations, one recurrent transition and two polymorphisms in a panel of 118 unrelated NF1 patients. Mutations in brief no. 229. Online.
    Peters H; Lüder A; Harder A; Schuelke M; Tinschert S
    Hum Mutat; 1999; 13(3):258. PubMed ID: 10090487
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular analysis of neurofibromatosis type 1 in Turkish families using polymorphic markers.
    Oğuzkan S; Cinbiş M; Ayter S; Anlar B; Aysun S
    Turk J Pediatr; 2003; 45(3):192-7. PubMed ID: 14696795
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reproductive decisions after prenatal diagnosis in neurofibromatosis type 1: importance of genetic counseling.
    Terzi YK; Oguzkan-Balci S; Anlar B; Aysun S; Guran S; Ayter S
    Genet Couns; 2009; 20(2):195-202. PubMed ID: 19650418
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A de novo Alu insertion results in neurofibromatosis type 1.
    Wallace MR; Andersen LB; Saulino AM; Gregory PE; Glover TW; Collins FS
    Nature; 1991 Oct; 353(6347):864-6. PubMed ID: 1719426
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Giant café-au-lait macule in neurofibromatosis 1: a type 2 segmental manifestation of neurofibromatosis 1?
    Yang CC; Happle R; Chao SC; Yu-Yun Lee J; Chen W
    J Am Acad Dermatol; 2008 Mar; 58(3):493-7. PubMed ID: 18280349
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BRCA1 mutation screening using restriction endonuclease fingerprinting-single-strand conformation polymorphism in an automated capillary electrophoresis system.
    Kringen P; Egedal S; Pedersen JC; Harbitz TB; Tveit KM; Berg K; Børresen-Dale AL; Andersen TI
    Electrophoresis; 2002 Dec; 23(24):4085-91. PubMed ID: 12481264
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Direct genomic multiplex PCR for BRCA1 and application to mutation detection by single-strand conformation and heteroduplex analysis.
    Barker DF
    Hum Mutat; 2000 Oct; 16(4):334-44. PubMed ID: 11013444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurofibromatosis type 1 (NF1): Identification of eight unreported mutations in NF1 gene in Italian patients [corrected].
    Origone P; Bellini C; Sambarino D; Banelli B; Morcaldi G; La Rosa C; Stanzial F; Castellan C; Coviello DA; Garrè C; Bonioli E
    Hum Mutat; 2003 Aug; 22(2):179-80. PubMed ID: 12872266
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurofibromatosis type 1 (NF1): the search for mutations by PCR-heteroduplex analysis on Hydrolink gels.
    Shen MH; Harper PS; Upadhyaya M
    Hum Mol Genet; 1993 Nov; 2(11):1861-4. PubMed ID: 7904209
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular studies in 20 submicroscopic neurofibromatosis type 1 gene deletions.
    Lopez Correa C; Brems H; Lázaro C; Estivill X; Clementi M; Mason S; Rutkowski JL; Marynen P; Legius E
    Hum Mutat; 1999; 14(5):387-93. PubMed ID: 10533064
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of denaturing high performance liquid chromatography (DHPLC) for the mutational analysis of the neurofibromatosis type 1 ( NF1) gene.
    Han SS; Cooper DN; Upadhyaya MN
    Hum Genet; 2001 Nov; 109(5):487-97. PubMed ID: 11735023
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.